Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1353 publications

The impact of GLP-1 agonists on sleep disorders: spotlight on sleep apnea.

The impact of GLP-1 agonists on sleep disorders: spotlight on sleep apnea.

Journal: Expert opinion on pharmacotherapy
Published: October 20, 2025

Effect of Tirzepatide in an Adolescent With Early-Onset Obesity, Hyperphagia, and Type 2 Diabetes.

Effect of Tirzepatide in an Adolescent With Early-Onset Obesity, Hyperphagia, and Type 2 Diabetes.

Journal: Cureus
Published: October 16, 2025

Tirzepatide protects the heart from doxorubicin-induced cardiotoxicity by modulating endoplasmic reticulum (ER) stress and HMGCoA reductase 1 expression.

Tirzepatide protects the heart from doxorubicin-induced cardiotoxicity by modulating endoplasmic reticulum (ER) stress and HMGCoA reductase 1 expression.

Journal: Cardiovascular research
Published: October 13, 2025

Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis.

Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis.

Journal: Journal of Crohn's & colitis
Published: October 10, 2025

Semaglutide (Wegovy) for MASH.

Semaglutide (Wegovy) for MASH.

Journal: The Medical letter on drugs and therapeutics
Published: October 08, 2025

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Journal: Best practice & research. Clinical endocrinology & metabolism
Published: September 27, 2025

Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data.

Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data.

Journal: Cardiovascular drugs and therapy
Published: September 27, 2025

Cardiovascular effects of incretin-based drugs in patients with and without a history of heart failure: a protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.

Cardiovascular effects of incretin-based drugs in patients with and without a history of heart failure: a protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.

Journal: BMJ open
Published: September 21, 2025

Legal Challenges to Compounding Drugs for Weight Loss.

Legal Challenges to Compounding Drugs for Weight Loss.

Journal: International journal of pharmaceutical compounding
Published: September 17, 2025

Tirzepatide for the treatment of adults living with concurrent type 1 diabetes and overweight or obesity (TZP-T1D): a double-blind, placebo-matched randomised controlled trial protocol.

Tirzepatide for the treatment of adults living with concurrent type 1 diabetes and overweight or obesity (TZP-T1D): a double-blind, placebo-matched randomised controlled trial protocol.

Journal: BMJ open
Published: September 17, 2025

Treating Prediabetes With Tirzepatide Helps Obese Patients Lose Weight and Decreases Likelihood of Type 2 Diabetes.

Treating Prediabetes With Tirzepatide Helps Obese Patients Lose Weight and Decreases Likelihood of Type 2 Diabetes.

Journal: American family physician
Published: September 17, 2025

Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects.

Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects.

Journal: Journal of medicinal chemistry
Published: September 17, 2025
Showing 1-12 of 1,353

Last Updated: 10/31/2025